25-hydroxycholesterol has been researched along with Muscular Atrophy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, M; Li, Y; Liang, C; Liu, B; Pan, X; Shen, C; Song, JL; Song, YH; Wang, J; Wang, X; Wu, C; Yu, XY; Zhao, Q; Zhou, J | 1 |
1 other study(ies) available for 25-hydroxycholesterol and Muscular Atrophy
| Article | Year |
|---|---|
Angiotensin-II-induced Muscle Wasting is Mediated by 25-Hydroxycholesterol via GSK3β Signaling Pathway.
Topics: Angiotensin II; Animals; Blotting, Western; Cell Line; Cells, Cultured; Gene Expression Profiling; Glycogen Synthase Kinase 3 beta; Hydroxycholesterols; Insulin-Like Growth Factor I; Male; Mice, Inbred C57BL; Mice, Knockout; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Myoblasts; Proto-Oncogene Proteins c-akt; Receptors, Tumor Necrosis Factor, Type I; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; SKP Cullin F-Box Protein Ligases; Steroid Hydroxylases; Thiadiazoles; Tumor Necrosis Factor-alpha | 2017 |